Hygenix Blog

A written 483 response may be "the primary or a key component" in FDA's evaluation of whether subsequent Agency…

Qualified vendors don’t always lose because of price, scope, or technical ability. Often, they lose momentum…

By the time a bid is issued, buyers have usually already formed a view of which vendors look credible enough to…

FDA’s Manufacturing PreCheck Pilot Program has moved from concept to an active intake and selection process.…

If you have received an Enhanced Turnover Package (ETOP) and felt immediate concern, you know the pattern: missing…

Under QMSR, cleanroom projects fail when leaders cannot demonstrate risk-based control of what was built, what…

During the 2025 project cycle, delays and deviations in cleanroom and GMP facility builds were traced not to…